Tufveson G, Riesenfeld I, Rönnblom L, Hedman A, Alm G V
J Natl Cancer Inst. 1977 Nov;59(5):1491-7. doi: 10.1093/jnci/59.5.1491.
Spleen cells from normal, nonimmune, CBA or (CBA X AKR)F1 mice markedly and rapidly inhibited the incorporation of [3H]thymidine by two different T-cell lymphomas in an in vitro cytostasis assay. These were the I-529 lymphoma of spontaneous AKR origin and the Moloney murine leukemia virus-induced YAC lymphoma of A mouse origin. Spleen cells were the most efficient inhibitors for both types of target cells, whereas lymph node cells were much less active and thymus cells showed little or no activity. Granulocytes, as well as conventional T- and B-lymphocytes, were excluded as important contributors to the cytostatic cell population. Spleen cells were separated on nylon wool, Sephadex G-10 columns, or plastic petri dishes and tested for activity in the cytostasis assay or for cytotoxicity against 51Cr-labeled lymphoma target cells. Adherent cells carried almost all cytostatic activity against the AKR lymphoma but also showed significant cytotoxic activity against these target cells. In addition, the cytostatic activity against the YAC lymphoma was mainly due to adherent spleen cells, but nonadherent cells were relatively more active against this target than against I-529 cells. Such nonadherent spleen cells further showed increased cytotoxic activity, compared to the whole spleen cell population.
在体外细胞生长抑制试验中,来自正常、未免疫的CBA或(CBA×AKR)F1小鼠的脾细胞能显著且迅速地抑制两种不同T细胞淋巴瘤对[3H]胸腺嘧啶核苷的掺入。这两种淋巴瘤分别是自发源自AKR的I-529淋巴瘤和由莫洛尼鼠白血病病毒诱导的源自A小鼠的YAC淋巴瘤。脾细胞对这两种靶细胞都是最有效的抑制剂,而淋巴结细胞活性低得多,胸腺细胞几乎没有活性或完全没有活性。粒细胞以及传统的T淋巴细胞和B淋巴细胞被排除是细胞生长抑制细胞群体的重要组成部分。脾细胞通过尼龙毛、葡聚糖凝胶G-10柱或塑料培养皿进行分离,并在细胞生长抑制试验中检测活性,或检测对51Cr标记的淋巴瘤靶细胞的细胞毒性。贴壁细胞对AKR淋巴瘤几乎具有所有细胞生长抑制活性,但对这些靶细胞也表现出显著的细胞毒性活性。此外,对YAC淋巴瘤的细胞生长抑制活性主要归因于贴壁脾细胞,但非贴壁细胞对该靶细胞的活性相对比对I-529细胞的活性更高。与整个脾细胞群体相比,这种非贴壁脾细胞还表现出增强的细胞毒性活性。